|
|
|
|
Science Sparks @ ACTREC
|
 25th July 2022 |
Vol. No. 11; Issue No. 536 |
|
|
Publications
|
|
1. Chopade P, Chopra S, Jain J, Panda S, Patil A, Patil G, Mahantshetty U, Engineer R, Gurram L, Mittal P, Ghosh J, Gupta S, Shrivastava K (2022). Serial bone density changes in women undergoing pelvic (chemo) radiation: Results from PARCER trial. International Journal of Radiation Oncology, Biology, Physics.
2. Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, Alone M, Ghosh J, Rath S, Gulia S, Gupta S (2022). Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer. International Journal of Radiation Oncology, Biology, Physics.
3. Chopade P, Maitre P, David S, Panigrahi G, Singh P, Phurailtpam R, Murthy V (2022). Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a? International Journal of Radiation Oncology, Biology, Physics.
4. Shukla P, Dange P, Mohanty BS, Gadewal N, Chaudhari P, Sarin R (2022). ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. Cancer Gene Therapy.
5. Sinha S, Laskar SG, Wadasadawala T, Krishnatry R, Lievens Y, Agarwal JP (2022). Adopting health economic research in radiation oncology: A perspective from low- or middle-income countries. JCO Global Oncology. 8: e2100374.
6. Sengar M, Fundytus A, Hopman W, Pramesh CS, Radhakrishnan V, Ganesan P, Mathew A, Lombe D, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM (2022). Cancer Medicines: What Is Essential and Affordable in India? JCO Global Oncology. 8:e2200060.
7. Rubagumya F, Sengar M, Ka S, Hammad N, Booth C, Karim S (2022). Choosing wisely—barriers and solutions to implementation in low and middle-income countries. Current Oncology. 29(7): 5091-5096.
Book Chapter
Joshi P, Ghadi S, Waghmare SK. (2022). Isolation of cancer stem cells from skin squamous cell carcinoma.In: Methods in Cell Biology. Academic Press Inc.
|
|
|
|
|
Interesting Reads
|
|
Ferguson ID, Patiño-Escobar B, Tuomivaara ST, Lin YT, Nix MA, Leung KK, Kasap C, Ramos E, Nieves Vasquez W, Talbot A, Hale M, Naik A, Kishishita A, Choudhry P, Lopez-Girona A, Miao W, Wong SW, Wolf JL, Martin TG 3rd, Shah N, Vandenberg S, Prakash S, Besse L, Driessen C, Posey AD Jr, Mullins RD, Eyquem J, Wells JA, Wiita AP. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 13(1): 4121, 2022.
|
|
|
Legends of Science
|
|
Ved Prakash Kamboj
Ved Prakash Kamboj obtained his Ph.D. from the Punjab University, Chandigarh, in 1965. His areas of specialization were Reproductive biology, Fertility regulation, and Endocrinology. He has played a significant role in developing the first nonsteroidal contraceptive pill. He initiated herbal drug development based on traditional knowledge and herbal drug wealth. He is an elected fellow of the Indian National Science Academy and the National Academy of Science, Allahabad. Dr. Kamboj has received the Ranbaxy Research award; Bharat Jyot Award; the Vigyan Gaurav Samman Award from the Council of Science and Technology, Uttar Pradesh.
|
|
| |
|
Palle Deva Prasada Rao
Palle Deva Prasada Rao received his Ph.D. from Vikram University, Ujjain. He demonstrated that specific CNS Neurons undergo remarkable regeneration. With the help of different neuronal tracers, he showed several intricate neuronal circuitries within the brain concerning the visual, olfactory, hypophysial, and spinal systems. Dr. Rao was an elected fellow of the National Academy of Sciences, Allahabad. He was awarded a fellowship by the Alexander von Humboldt Foundation, Germany.
|
|
| |
|
|
|
|
Do You Know?
In 1988, Pivotal clinical trial showed that chemotherapy following surgery (adjuvant treatment) in patients with stage III colorectal cancer reduces the risk of cancer recurrence by about 40 percent.
|
|
|
|
Cancer News
|
|
|
| |
|
|
| |
|
New therapy for non-small cell lung cancer
|
|
21 July 2022, Sciworthy
|
|
The researchers found that the lymphocytes could spread out from most of the patient’s tumors and were capable of finding the tumors so that they could kill the cancer cells... |
|
|
| |
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
